GlassScriptPhysician profile
Heather D Rhoden
NPI 1336109073
$1,689.25
in general payments reported to CMS, 2019-2025
26 companies · $395 in 2025
The $395 reported for 2025 was more than what 90% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $180 · 2020: $132 · 2021: $179 · 2022: $194 · 2023: $345 · 2024: $265 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,005.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,004.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $270.02 | 2019-2025 | Dyanavel Xr |
| Davol INC. | $149.81 | 2023 | Phasix Mesh |
| Pfizer INC. | $145.43 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $127.45 | 2022-2025 | Vaxelis, Gardasil 9, Vaxneuvance |
| Cranial Technologies, INC | $124.35 | 2019-2025 | Doc Band |
| Sanofi-Aventis U.S. LLC | $113.28 | 2024-2025 | |
| Seqirus USA INC | $95.47 | 2022-2025 | Flucelvax, Flucelvax Quadrivalent |
| Adlon Therapeutics L.P. | $79.91 | 2020-2021 | |
| Cumberland Pharmaceuticals, INC. | $74.61 | 2019-2025 | Kristalose |
| Sobi, INC | $69.43 | 2021 | |
| Ironshore Pharmaceuticals INC. | $61.82 | 2019-2020 | |
| Sanofi Pasteur INC. | $56.17 | 2021-2024 | |
| Alk-Abello, INC | $39.92 | 2025 | Neffy |
| Biomarin Pharmaceutical INC. | $31.28 | 2025 | Voxzogo 1.2mg |
| Shire North American Group INC | $31.26 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $29.81 | 2022-2025 | Immunocap |
| Kyowa Kirin, INC. | $24.45 | 2024 | Crysvita |
| Aroa Biosurgery Incorporated | $23.18 | 2022 | |
| Vertical Pharmaceuticals, LLC | $22.69 | 2019 | |
| Myriad Genetic Laboratories, INC. | $20.39 | 2021 | |
| Glaxosmithkline, LLC. | $19.90 | 2025 | Bexsero |
| Nestle Healthcare Nutrition INC. | $19.53 | 2023 | |
| Integra Lifesciences Corporation | $18.07 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Cipher Pharmaceuticals US LLC | $14.60 | 2025 | Spinosad, Natroba |
| Collegium Pharmaceutical, INC. | $14.17 | 2025 | Jornay Pm |
| Aytu Biopharma, INC. | $12.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Rhoden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.